Parse Biosciences and Codebreaker Labs launched a collaboration to pair Codebreaker’s engineered variant libraries with Parse’s single‑cell transcriptomics platform to experimentally map how genetic variants alter cell‑level expression. The deal aims to generate large functional datasets to inform whole‑genome interpretation, target validation and AI model training. Parse’s technology integration follows Qiagen’s pending acquisition of Parse and reflects growing industry investment in large, labeled single‑cell perturbation datasets.